MCE 的所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务。

AT-1002 TFA

CAS No. :

MCE 站：AT-1002 TFA

产品活性：AT-1002 TFA 是一种 6 聚体合成肽，是一种紧密连接 (junction) 的调节剂和吸收增强剂。

研究领域：Cytoskeleton

作用靶点：Gap Junction Protein

In Vitro: AT-1002, a 6-mer synthetic peptide, belongs to an emerging novel class of compounds that reversibly increase paracellular transport of molecules across the epithelial barrier. AT-1002 can undergo Cys-Cys dimerization.
Undifferentiated Caco-2 cells are treated with AT-1002 (0 to 5 mg/mL, 3 or 24 hours) and viability is assessed by measuring cellular ATP content. Treatment with AT-1002 for up to 3 h does not affect cell viability at any concentration. In particular, the viability of Caco-2 cells is not affected by 5 mg/mL AT-1002. AT-1002 reduces cell viability after 24 h at concentrations of 2.5 mg/mL and higher. However, the cells remain viable after 24 h if the cells are washed after exposure to AT-1002 for 3 h indicating that AT-1002 does not irreversibly damage cells.

相关产品：Covalent Screening Library Plus  |  Covalent Screening Library  |  Bioactive Compound Library Plus  |  Cytoskeleton Compound Library  |  Larazotide acetate  |  Tonabersat  |  Danegaptide Hydrochloride  |  Gap 27  |  Gap 26  |  Meclofenamate sodium  |  Gap19 TFA  |  Rotigaptide  |  Carbenoxolone disodium  |  AT-1002

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。